Schonfeld Strategic Advisors LLC Kala Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$2.62 - $5.43 $106,956 - $221,668	-40,823 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.06 - $8.15 $11,521 - $18,557	-2,277 Reduced 5.28%	40,823 $216,000
Q1 2021 May 17, 2021	BUY	$6.24 - $9.58 $268,944 - $412,898	43,100 New	43,100 $290,000
Q4 2020 Feb 16, 2021	SELL	$6.28 - $8.79 $307,720 - $430,709	-49,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$7.5 - $11.11 $367,500 - $544,390	49,000 New	49,000 $0

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.82M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.